Task: Answer the multiple choice question.
Question: Which compound exhibits a -1.359% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1cc(OC)nc(NC(=O)COC(=O)C2CCCCC2)n1
b CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
Answer: b. CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
CCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
2-methyl-3-nitro-N-[3-(propanoylamino)phenyl]benzamide